Ozempic: A Comprehensive Review

Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist administered once weekly via injection.

It was initially approved for use in adults with type 2 diabetes in 2017[1]. Ozempic is often prescribed in conjunction with diet and exercise to improve glycemic control.

More recently, it has gained significant attention for its role in weight management, although it is important to note that Ozempic is not explicitly approved for weight loss[2].

This comprehensive review aims to provide detailed information about Ozempic, including its intended uses, potential benefits and side effects, dosage information, and alternative treatments.

Intended Use

Ozempic is primarily indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes[3].

It is also approved to reduce the risk of major adverse cardiovascular events (such as heart attack, stroke, or death) in adults with type 2 diabetes and established cardiovascular disease[3].

In addition, Ozempic lowers heart-related risks in people with both diabetes and heart disease[1].

Furthermore, Ozempic is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease[3].

How Ozempic Works

Cost and Insurance Coverage

The cost of Ozempic can vary depending on several factors, including insurance coverage and the pharmacy used. Without insurance, Ozempic can cost around $968.52 per month, on average[4].

However, savings programs and coupons can help lower the medication cost. The list price for Ozempic depends on the product formulation your healthcare provider prescribes[5]:

Formulation	List Price
Ozempic® 0.25 or 0.5 mg (1 x 1.5-mL pen)	$997.58
Ozempic® 1 mg (1 x 3-mL pen)	$997.58
Ozempic® 2 mg (1 x 3-mL pen)	$997.58

Most commercial prescription plans cover some or all of the cost for Ozempic when used to treat type 2 diabetes, but it is not frequently covered for weight loss[6].

You can also call Novocare, a support program from the manufacturer Novo Nordisk, to determine your cost estimate for Ozempic by phone or online.

Affordable Options and Coverage Alternatives

For those concerned about the high cost of Ozempic, several options may help make the medication more affordable:

The Novo Nordisk Savings Card program can significantly reduce out-of-pocket costs for eligible patients with commercial insurance, offering maximum savings of $100 for a 1-month prescription, $200 for a 2-month prescription, and $300 for a 3-month prescription.

Individuals who meet certain eligibility requirements may qualify for the Novo Nordisk Patient Assistance Program (PAP), which provides Ozempic at no cost to qualified patients.

Alternative GLP-1 receptor agonists such as Trulicity, Victoza, and Rybelsus may be more affordable options with similar therapeutic effects, depending on your insurance coverage.

Patient advocacy services like Simplefill can help evaluate your situation and identify the most appropriate assistance programs to make Ozempic more accessible.

Medicare patients who fall into the coverage gap (commonly known as the “donut hole”) may be eligible for the Low Income Subsidy program, which can provide additional financial support for prescription medications.

Free prescription discount cards such as GoodRx can offer savings on Ozempic, even for those without insurance coverage.

Effectiveness in Treating Type 2 Diabetes

Ozempic has been shown to be effective in lowering blood glucose levels and reducing the risk of health complications in patients with type 2 diabetes[7].

Studies have demonstrated that Ozempic can lower levels of HbA1c (a measure of blood glucose) by between 1.2 and 1.8 percentage points over 10 to 13 months.

In these studies, Ozempic compared favorably with other treatments, such as sitagliptin, exenatide, and insulin glargine.

A clinical trial (FLOW phase 3b) found that Ozempic use in adults with type 2 diabetes and CKD resulted in a 24% lower risk of their kidney disease worsening and a 4.9% lower risk of dying from heart problems[8].

The efficacy of once-weekly subcutaneous (s.c.) semaglutide was evaluated in over 7,000 patients in six global phase IIIa trials and nearly 3,000 patients in four phase IIIb trials (SUSTAIN program)[9].

These trials documented a statistically significant risk reduction of major cardiovascular events for once-weekly semaglutide versus a placebo.

Guidelines by the American Diabetes Association (ADA) recommend using a GLP-1 agonist, such as Ozempic, in adults with type 2 diabetes who also have one of the following conditions[10]:

• Cardiovascular disease (CVD) or a high risk of developing CVD
• Kidney disease
• Heart failure

These same guidelines also recommend using another medication, such as a GLP-1 agonist like Ozempic, as an option for treating people with type 2 diabetes in whom metformin doesn’t adequately lower their blood sugar.

Effectiveness in Weight Loss

While Ozempic is not officially approved for weight loss[2], it has shown promise in this area. In clinical trials, many people lost weight while using Ozempic together with counseling for lifestyle, habit, and diet changes.

Adults lost an average of 8 pounds with the 0.5 mg dose and 10 pounds with the 1 mg dose compared to 3 pounds with a placebo[11]. Adults also lost an average of 12 pounds with the 1 mg dose and 14 pounds with the 2 mg dose.

It is important to note that these results may vary, and Ozempic should not be used for weight loss unless prescribed by a healthcare professional.

Ozempic influences the part of the brain that allows us to feel hunger and satiety[12]. As a result, patients eat less because they don’t feel as hungry and remain fuller for longer.

In one study using Wegovy, participants experienced an average weight loss of about 15–18% of their initial body weight over 68 weeks. By comparison, participants taking Ozempic lost about 6–10% of their body weight.

It is important to note that if you start taking Ozempic for medical weight loss, your body may get used to it, establishing a new normal[13]. This can cause your weight to plateau. Research has shown that if you stop taking Ozempic, it is likely that you will regain the weight you lost.

Dosage

Ozempic is administered once weekly via injection under the skin of the belly, thigh, or upper arm[7]. The starting dose is typically 0.25 mg once a week for the first 4 weeks[15].

After 4 weeks, the dose is usually increased to 0.5 mg once weekly. If needed, the dose can be further increased up to a maximum of 2 mg once a week.

The day of weekly administration can be changed if necessary as long as the time between two doses is at least 2 days (>48 hours) 16.

Potential Side Effects

The most common side effects with Ozempic include gastrointestinal problems[17]. These side effects are usually mild to moderate in severity and of short duration.

More serious side effects have been reported but are less common[18].

More common side effects include:

• Nausea
• Vomiting
• Diarrhea
• Stomach pain
• Constipation

Less common side effects include:

• Inflammation of the pancreas (pancreatitis)
• Changes in vision
• Low blood sugar (hypoglycemia)
• Kidney problems
• Serious allergic reactions
• Gallbladder problems

Ongoing Clinical Trials

Several clinical trials involving Ozempic are currently underway. These trials are investigating the use of Ozempic in various populations and for different indications, including:

• Understanding Ozempic Adherence: A research study to understand how people with type 2 diabetes take Ozempic and if the Ozempic app helps them stay on this treatment[19].
  This study aims to improve medication adherence and support patients in managing their diabetes effectively.
• Evaluating CagriSema: Multiple clinical trials are investigating the impact of CagriSema, a combination of semaglutide and cagrilintide, on blood sugar, weight, and heart disease in people with obesity or type 2 diabetes[20].
  These trials explore the potential of combining two medications to achieve better outcomes for patients with metabolic conditions.
• Preventing Cardiovascular Events: A clinical trial in the UK is underway to find out if regularly taking oral semaglutide can help to prevent heart attacks, strokes, and other health problems in people with type 2 diabetes[21].
  This trial investigates the potential of oral semaglutide to reduce cardiovascular risk in a large population of patients with type 2 diabetes.

Alternative Treatments

Several alternative treatments are available for type 2 diabetes and weight loss. These include other GLP-1 receptor agonists, older oral medications, and lifestyle modifications[22].

Medication	Drug Class	Dosage Form	Additional Benefits
Rybelsus (semaglutide)	GLP-1	Oral tablet taken once daily	May cause a small amount of weight loss
Mounjaro (tirzepatide)	GLP-1	Weekly injection	May cause a significant amount of weight loss
Trulicity (dulaglutide)	GLP-1	Weekly injection	May aid with weight loss, kidney health, and heart health
Victoza (liraglutide)	GLP-1	Daily injection	May aid with weight loss, kidney health, and heart health
Bydureon BCise (exenatide)	GLP-1	Weekly injection	May cause a small amount of weight loss
Byetta (exenatide)	GLP-1	Twice-daily injection	May cause a small amount of weight loss

Patient Reviews and Testimonials

Patient reviews and testimonials about Ozempic are generally positive, with many people reporting significant weight loss and improved blood sugar control[24].

One patient, Brittany R., shared that Ozempic helped her stop overeating and lose 16 pounds in four weeks.

Another patient, Hailey, highlighted the positive impact of Ozempic on her confidence and relationships, as she was able to lose weight and become more active with her son[25].

However, some patients have experienced side effects, such as nausea and vomiting[26]. In a case study reported by NBC News, three women shared their experiences with Ozempic.

Two of the women experienced nausea and vomiting while on the drug, but they also lost a significant amount of weight.

One woman, Danielle, stopped taking Ozempic after three months due to discomfort from nausea and headaches and experienced a rebound effect, gaining back the weight she had lost and then some.

It is important to discuss any concerns or questions about Ozempic with a healthcare professional.

Conclusion

Ozempic is a valuable medication for managing type 2 diabetes and reducing the risk of cardiovascular complications. It has also shown promise in weight management, although further research is needed to fully understand its long-term effects in this area.

While Ozempic can be an effective treatment option, it is essential to be aware of the potential side effects and discuss any concerns with a healthcare professional. The cost of Ozempic can be a barrier for some patients, and insurance coverage for weight loss is often limited. Patients should carefully weigh the benefits and drawbacks of Ozempic, considering factors such as cost, potential side effects, and the need for ongoing treatment.

The development of GLP-1 receptor agonists like Ozempic marks a significant advancement in the treatment of obesity and related metabolic conditions. These medications offer a new approach to weight management by targeting the underlying hormonal mechanisms that contribute to weight gain.

As research continues and new medications emerge, GLP-1 receptor agonists are likely to play an increasingly important role in addressing the growing global health challenges of obesity and diabetes.

This information should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment.